Learn how Nephrocare Health Services Ltd’s IPO performed on its opening day, including subscription details, price band, lot size, key timelines, and application steps through ASBA or UPI.
The Nephrocare Health Services Ltd IPO opened for subscription on 10 December 2025, marking the public market debut of a healthcare services provider that operates across the nephrology and renal care segment. The company delivers a range of clinical services including dialysis care, kidney health management, and specialty medical solutions. Its public issue has drawn attention from investors who are tracking India’s expanding demand for accessible chronic-care services.
With an issue size of ₹871.05 Cr and a price band set between ₹438 and ₹460 per share, Nephrocare Health Services aims to raise capital for expansion, technology enhancement, and service capacity strengthening. Its presence across multiple states and focus on speciality care make the IPO relevant to investors seeking exposure to India’s healthcare growth cycle.